You are here
The Lasker Scholars program provides a unique opportunity for clinician-scientists to receive a combination of intramural and extramural NIH research support.
The program has two phases. The first phase will support scholars in the IRP for 5 years, with the possibility of an extension of this phase for an additional 2 years. Lasker Scholars will be appointed as independent tenure-track investigators within an NIH Institute or Center, a process that includes being hired as a full time employee at the NIH and completing the procedures required of new Federal government employees. The IRP will provide space, research expenses, full salary, and Federal employee benefits. Scholars will develop independent research activities over the course of their stay in the IRP, and will be formally reviewed by a panel of senior extramural investigators every 2 to 4 years to evaluate their research progress.
Upon successfully completing the initial IRP phase of the program, the Lasker Scholar will be eligible for two options in the second phase:
Option 1. Remain in the IRP with continued intramural funding and progression to tenured senior investigator status after appropriate assessment. Retention in the IRP will be dependent on the development of a mutual agreement between the Scholar and the IRP. Tenure at the NIH requires evaluation and approval by the NIH Deputy Director for Intramural Research.
Option 2. The Scholar can receive up to 3 years of support to continue independent research at an extramural sponsoring institution. This support is contingent upon obtaining an appropriate extramural position at an eligible institution, and the successful NIH programmatic review of the scholar’s progress during the intramural phase of the award. Lasker Scholars can request direct costs of up to $499,000/year (plus applicable indirect costs). Scholars must complete 5 years of research in the IRP to be eligible for the extramural Lasker Scholars Grant.
Research Areas of Interest
The Intramural Research Program will give highest priority to those applications which propose research within the fields given below, listed by participating Institutes/Centers. Applicants are strongly advised to contact the Institute/Center scientific contact person listed in the Program Announcement, to obtain feedback regarding the programmatic appropriateness of their research to the goals of the NIH intramural research program.
National Cancer Institute
- Medical oncology, pediatric hematology-oncology, radiation oncology, surgical oncology, pathology, neuro-oncology, urology and dermatology. Specific areas within these categories include genitourinary oncology, lymphoid malignancies, neuro-oncology, immunotherapy, women's cancers, aeoro-digestive cancers, molecular diagnostics, and functional imaging.
- Translational and clinical epidemiology, genetics of cancer
National Eye Institute
- Neurodegenerative eye disease, neuro-immunology and immunometabolism
National Heart, Lung, and Blood Institute
- Cardiovascular blood and pulmonary research: regenerative medicine, pediatric and developmental biology
- Cardiovascular research: heart failure, cardio-oncology, interventional therapeutics
- Blood research: chronic myeloproliferative disorders, benign hematology, bone marrow failure syndromes, myelodysplastic syndromes, hematological malignancies, and hematopoietic stem cell transplantation
- Pulmonary research: pulmonary interstitial disease, pulmonary hypertension, airway inflammation, host defense mechanisms, rare lung disease, pulmonary mycobacterial disease
- Sickle cell research
- Tumor immunology and immunotherapy
National Institute of Allergy and Infectious Diseases
- Vector biology and antimicrobial resistance
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Genetics, genomics, pathophysiology, prevention, and treatment of rheumatic diseases, particularly systemic lupus erythematosus, systemic vasculitis, inflammatory arthritis, inflammatory muscle disease, ankylosing spondylitis and spondyloarthropathies, and auto-inflammatory syndromes.
- Psoriasis and inflammatory skin diseases.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Metabolic diseases
- Bone growth and skeletal dysplasia
- Endocrinology and molecular genetics
- Regenerative medicine and stem cell biology
- Reproductive and molecular medicine
- Developmental biology and human genetics
- Women’s health
National Institute of Dental and Craniofacial Research
- Craniofacial anomalies, including genetics, pathophysiology, and surgical therapies
- Craniofacial regenerative medicine, tissue engineering, stem cell biology
- Craniofacial and dental developmental biology and human genetics
- Metabolic bone disease
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Drug Abuse
- Substance use disorders
National Institute of Environmental Health Sciences
- Metabolic diseases
- Reproductive - puberty, estrogen effects, menopause
- Women's health including bone health
- Pulmonary diseases
- Human genetics
- Environmental exposures
- Health disparities
National Institute of Mental Health
- Psychosis - underlying neurological mechanisms, pathophysiology and potential therapeutics
National Institute of Neurological Disorders and Stroke
- Any area of neurology or stroke
National Institute of Nursing Research
- Symptom science/biology within a clinical context
This page last reviewed on April 12, 2017